| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/NI.2534 |
| P698 | PubMed publication ID | 23334791 |
| P50 | author | Hergen Spits | Q89927093 |
| P2093 | author name string | Willem A Bemelman | |
| Kees Weijer | |||
| Nicolas Legrand | |||
| Sybren L Meijer | |||
| Anje A te Velde | |||
| Christianne J Buskens | |||
| Charlotte P Peters | |||
| Jenny M Mjösberg | |||
| Jochem H Bernink | |||
| Hulda S Hreggvidsdottir | |||
| Marius Munneke | |||
| Sigrid E Heinsbroek | |||
| P2860 | cites work | The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells | Q39260231 |
| The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. | Q40990833 | ||
| Functional Differences between Human NKp44(-) and NKp44(+) RORC(+) Innate Lymphoid Cells | Q41838358 | ||
| T-bet is required for optimal proinflammatory CD4+ T-cell trafficking. | Q41862330 | ||
| Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. | Q41904687 | ||
| Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage | Q42786917 | ||
| Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells | Q42915172 | ||
| A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells | Q43905966 | ||
| Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. | Q45200144 | ||
| Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense | Q46197286 | ||
| Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells | Q46231038 | ||
| Sequential polarization and imprinting of type 1 T helper lymphocytes by interferon-gamma and interleukin-12. | Q47898451 | ||
| Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells with stroma of the T cell zone. | Q52586488 | ||
| Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. | Q53590422 | ||
| Monitoring the effect of gene silencing by RNA interference in human CD34+ cells injected into newborn RAG2-/- gammac-/- mice: functional inactivation of p53 in developing T cells. | Q53888112 | ||
| The Natural Cytotoxicity Receptor NKp46 Is Dispensable for IL-22-Mediated Innate Intestinal Immune Defense against Citrobacter rodentium | Q57194289 | ||
| Lineage Relationship Analysis of RORγt+Innate Lymphoid Cells | Q57520258 | ||
| Regulation of Cytokine Secretion in Human CD127+ LTi-like Innate Lymphoid Cells by Toll-like Receptor 2 | Q58478673 | ||
| A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127 | Q58478714 | ||
| Lymphotoxin alphabeta is expressed on recently activated naive and Th1-like CD4 cells but is down-regulated by IL-4 during Th2 differentiation | Q78109594 | ||
| Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation | Q83678198 | ||
| Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161 | Q84933191 | ||
| A novel transcription factor, T-bet, directs Th1 lineage commitment | Q22253874 | ||
| Systemically dispersed innate IL-13-expressing cells in type 2 immunity | Q24623563 | ||
| Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity | Q24630261 | ||
| Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22 | Q24655076 | ||
| Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system | Q24680733 | ||
| Transcriptional control of innate lymphoid cells | Q27005868 | ||
| Anti-interleukin-12 antibody for active Crohn's disease | Q28292686 | ||
| A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity | Q28299539 | ||
| Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice | Q28594052 | ||
| Inflammatory bowel disease | Q29615500 | ||
| Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells | Q29619771 | ||
| Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity | Q33934522 | ||
| The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. | Q34152180 | ||
| Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases | Q34181228 | ||
| Innate lymphoid cells: emerging insights in development, lineage relationships, and function | Q34245256 | ||
| Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial | Q34275637 | ||
| Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt(+) innate lymphocytes | Q34591589 | ||
| Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity | Q35624378 | ||
| Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. | Q35634065 | ||
| Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus | Q35872309 | ||
| Evidence for discrete stages of human natural killer cell differentiation in vivo | Q36228536 | ||
| Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease | Q36390314 | ||
| Development of human lymphoid cells | Q36427345 | ||
| Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice | Q37111353 | ||
| T-bet in disease. | Q37891668 | ||
| IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease | Q38423061 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 221-229 | |
| P577 | publication date | 2013-01-20 | |
| P1433 | published in | Nature Immunology | Q1071725 |
| P1476 | title | Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues | |
| P478 | volume | 14 |
| Q41453369 | "Multi-Omics" Analyses of the Development and Function of Natural Killer Cells |
| Q40290672 | A Human Lin- CD123+ CD127low Population Endowed with ILC Features and Migratory Capabilities Contributes to Immunopathological Hallmarks of Psoriasis |
| Q36970818 | A Progenitor Cell Expressing Transcription Factor RORγt Generates All Human Innate Lymphoid Cell Subsets |
| Q36210450 | A Reproducible Method for Isolation and In Vitro Culture of Functional Human Lymphoid Stromal Cells from Tonsils |
| Q43905966 | A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells |
| Q90494825 | A circadian clock is essential for homeostasis of group 3 innate lymphoid cells in the gut |
| Q46758818 | A distinct innate lymphoid cell population regulates tumor-associated T cells |
| Q58478618 | A functional DC cross talk promotes human ILC homeostasis in humanized mice |
| Q34050062 | A new player on the psoriasis block: IL-17A- and IL-22-producing innate lymphoid cells. |
| Q37369583 | A proof-of-concept study with the tyrosine kinase inhibitor nilotinib in spondyloarthritis |
| Q55332187 | Activated innate lymphoid cell populations accumulate in human tumour tissues. |
| Q90628227 | Acute cellular rejection in small-bowel transplantation impairs NCR+ innate lymphoid cell subpopulation 3/interleukin 22 axis |
| Q92092241 | Adipose group 1 innate lymphoid cells promote adipose tissue fibrosis and diabetes in obesity |
| Q28083360 | Along the Axis between Type 1 and Type 2 Immunity; Principles Conserved in Evolution from Fish to Mammals |
| Q98159044 | Ambiguous roles and potential therapeutic strategies of innate lymphoid cells in different types of tumor |
| Q55208795 | Ambiguous roles of innate lymphoid cells in chronic development of liver diseases. |
| Q64963771 | An Essential Role of Innate Lymphoid Cells in the Pathophysiology of Graft-vs.-Host Disease. |
| Q38964535 | An in vitro model of innate lymphoid cell function and differentiation. |
| Q38233854 | An overview of the role of innate lymphoid cells in gut infections and inflammation |
| Q42317622 | Aryl hydrocarbon receptor signaling involves in the human intestinal ILC3/ILC1 conversion in the inflamed terminal ileum of Crohn's disease patients |
| Q33759935 | Beyond NK cells: the expanding universe of innate lymphoid cells. |
| Q33958449 | Blowing on embers: commensal microbiota and our immune system |
| Q51634683 | Brief Report: Altered Innate Lymphoid Cell Subsets in Human Lymph Node Biopsy Specimens Obtained During the At-Risk and Earliest Phases of Rheumatoid Arthritis. |
| Q38577294 | CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. |
| Q34216673 | CD8αα⁺ innate-type lymphocytes in the intestinal epithelium mediate mucosal immunity |
| Q33964256 | CX₃CR1⁺ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. |
| Q102211064 | Campylobacter infection promotes IFNγ-dependent intestinal pathology via ILC3 to ILC1 conversion |
| Q42114048 | Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells. |
| Q31034892 | Characterization and Quantification of Innate Lymphoid Cell Subsets in Human Lung |
| Q90093161 | Characterization of Rat ILCs Reveals ILC2 as the Dominant Intestinal Subset |
| Q91663496 | Characterization of Transcriptional Regulatory Networks that Promote and Restrict Identities and Functions of Intestinal Innate Lymphoid Cells |
| Q37652760 | Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis |
| Q102058927 | Characterization of the pathoimmunology of necrotizing enterocolitis reveals novel therapeutic opportunities |
| Q39193836 | Chronic alcohol consumption inhibits peripheral NK cell development and maturation by decreasing the availability of IL-15. |
| Q28066226 | Close Encounters of Lymphoid Cells and Bacteria |
| Q38882799 | Colonization and effector functions of innate lymphoid cells in mucosal tissues |
| Q64102152 | Commensal and Pathogenic Bacteria Indirectly Induce IL-22 but Not IFNγ Production From Human Colonic ILC3s via Multiple Mechanisms |
| Q54970393 | Commentary: Neuronal regulation of type 2 innate lymphoid cells via neuromedin U. |
| Q36372127 | Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy |
| Q40173120 | Composition and functionality of the intrahepatic innate lymphoid cell-compartment in human nonfibrotic and fibrotic livers |
| Q39012808 | Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients. |
| Q36116749 | Composition, Development, and Function of Uterine Innate Lymphoid Cells |
| Q41323743 | Continuous IL-23 stimulation drives ILC3 depletion in the upper GI tract and, in combination with TNFα, induces robust activation and a phenotypic switch of ILC3. |
| Q33958127 | Contrasting immune responses mediate Campylobacter jejuni-induced colitis and autoimmunity |
| Q30240201 | Crohn's disease |
| Q35785264 | Cross-talk between type 3 innate lymphoid cells and the gut microbiota in inflammatory bowel disease |
| Q90176799 | Crosstalk Between Gut Microbiota and Innate Immunity and Its Implication in Autoimmune Diseases |
| Q28077126 | Crosstalk between Innate Lymphoid Cells and Other Immune Cells in the Tumor Microenvironment |
| Q64249883 | Curcumin and Intestinal Inflammatory Diseases: Molecular Mechanisms of Protection |
| Q50317364 | Cytokine Networks between Innate Lymphoid Cells and Myeloid Cells. |
| Q39206254 | Cytokines in inflammatory bowel disease |
| Q93269704 | Cytokines regulate the antigen-presenting characteristics of human circulating and tissue-resident intestinal ILCs |
| Q90733032 | Dazed and Confused: NK Cells |
| Q51739535 | Death Receptor 3 Signaling Controls the Balance between Regulatory and Effector Lymphocytes in SAMP1/YitFc Mice with Crohn's Disease-Like Ileitis. |
| Q64079803 | Deciphering the Roles of Innate Lymphoid Cells in Cancer |
| Q26861554 | Deciphering the transcriptional switches of innate lymphoid cell programming: the right factors at the right time |
| Q57181208 | Deconstructing deployment of the innate immune lymphocyte army for barrier homeostasis and protection |
| Q57279744 | Decreased CRTH2 Expression and Response to Allergen Re-stimulation on Innate Lymphoid Cells in Patients With Allergen-Specific Immunotherapy |
| Q89884081 | Deficient Regulatory Innate Lymphoid Cells and Differential Expression of miRNAs in Acute Myeloid Leukemia Quantified by Next Generation Sequence |
| Q38252608 | Development, differentiation, and diversity of innate lymphoid cells |
| Q36922081 | Developmental Acquisition of Regulomes Underlies Innate Lymphoid Cell Functionality |
| Q90496017 | Differential Modulation of Human Innate Lymphoid Cell (ILC) Subsets by IL-10 and TGF-β |
| Q48300283 | Dissecting human ILC heterogeneity: more than just three subsets. |
| Q36922183 | Distinct Gene Regulatory Pathways for Human Innate versus Adaptive Lymphoid Cells. |
| Q50298581 | Distinguishing Human Peripheral Blood NK Cells from CD56dimCD16dimCD69+CD103+ Resident Nasal Mucosal Lavage Fluid Cells. |
| Q88538287 | Diverse developmental pathways of intestinal intraepithelial lymphocytes |
| Q90543550 | Dynamic changes of innate lymphoid cells in acute ST-segment elevation myocardial infarction and its association with clinical outcomes |
| Q28075218 | Dysregulation of Group 3 Innate Lymphoid Cells in the Pathogenesis of Inflammatory Bowel Disease |
| Q41990559 | Dysregulation of Innate Lymphoid Cells in Common Variable Immunodeficiency |
| Q58572595 | Effect of Tyrosin Kinase Inhibitors on NK Cell and ILC3 Development and Function |
| Q37346684 | Emerging concepts and future challenges in innate lymphoid cell biology |
| Q38741014 | Enrichment of IL-17A+ IFN-γ+ and IL-22+ IFN-γ+ T cell subsets is associated with reduction of NKp44+ ILC3s in the terminal ileum of Crohn's disease patients. |
| Q90476090 | Enteric bacteria induce IFNγ and Granzyme B from human colonic Group 1 Innate Lymphoid Cells |
| Q97067660 | Eomes Expression Defines Group 1 Innate Lymphoid Cells During Metastasis in Human and Mouse |
| Q37422433 | Eomeshi NK Cells in Human Liver Are Long-Lived and Do Not Recirculate but Can Be Replenished from the Circulation |
| Q47157539 | Epigenomic Views of Innate Lymphoid Cells |
| Q36080691 | Epithelial-intrinsic IKKα expression regulates group 3 innate lymphoid cell responses and antibacterial immunity. |
| Q50027164 | Essential immunologic orchestrators of intestinal homeostasis. |
| Q33874975 | Establishment and function of tissue-resident innate lymphoid cells in the skin |
| Q36900160 | Expansion of inflammatory innate lymphoid cells in patients with common variable immune deficiency |
| Q92500913 | Expression of c-Kit discriminates between two functionally distinct subsets of human type 2 innate lymphoid cells |
| Q48021383 | Flt3 ligand expands bona fide innate lymphoid cell precursors in vivo |
| Q26824328 | From genetics of inflammatory bowel disease towards mechanistic insights |
| Q39034173 | Functional and phenotypic heterogeneity of group 3 innate lymphoid cells |
| Q92215594 | Functional interactions between innate lymphoid cells and adaptive immunity |
| Q37576715 | Gata3 drives development of RORγt+ group 3 innate lymphoid cells. |
| Q50317203 | Genome-wide association studies in Crohn's disease: Past, present and future. |
| Q87994387 | Gpr109a Limits Microbiota-Induced IL-23 Production To Constrain ILC3-Mediated Colonic Inflammation |
| Q38122453 | Group 2 innate lymphoid cells in lung inflammation |
| Q28081074 | Group 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice |
| Q37448373 | Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora. |
| Q38602944 | Group 3 innate lymphoid cells: regulating host-commensal bacteria interactions in inflammation and cancer |
| Q39167526 | Guards at the gate: physiological and pathological roles of tissue-resident innate lymphoid cells in the lung |
| Q41918189 | Guidelines for the use of flow cytometry and cell sorting in immunological studies |
| Q35677343 | Gut Microbiota and Immunity: Possible Role in Sudden Infant Death Syndrome |
| Q92154266 | HCMV Infection in a Mesenchymal Stem Cell Niche: Differential Impact on the Development of NK Cells versus ILC3 |
| Q59128967 | Hallmarks of primate lentiviral immunodeficiency infection recapitulate loss of innate lymphoid cells |
| Q89736301 | Helper Innate Lymphoid Cells in Human Tumors: A Double-Edged Sword? |
| Q64244231 | Heterogeneity of NK Cells and Other Innate Lymphoid Cells in Human and Murine Decidua |
| Q34257404 | Human CD117 (cKit)+ innate lymphoid cells have a discrete transcriptional profile at homeostasis and are expanded during filarial infection |
| Q64067984 | Human Gut-Associated Natural Killer Cells in Health and Disease |
| Q42347302 | Human ILC1: To Be or Not to Be. |
| Q58781730 | Human Innate Lymphoid Cells: Their Functional and Cellular Interactions in Decidua |
| Q36126996 | Human group3 innate lymphoid cells express DR3 and respond to TL1A with enhanced IL-22 production and IL-2-dependent proliferation |
| Q39306754 | Human innate lymphoid cells (ILCs) in filarial infections |
| Q48535338 | Human innate lymphoid cells (ILCs): Toward a uniform immune-phenotyping. |
| Q47099669 | Human intrahepatic ILC2 are IL-13positive amphiregulinpositive and their frequency correlates with model of end stage liver disease score. |
| Q34157945 | ID'ing innate and innate-like lymphoid cells |
| Q51530407 | IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity. |
| Q36767462 | IL-12 drives functional plasticity of human group 2 innate lymphoid cells |
| Q61809310 | IL-15 Generates IFN-γ-producing Cells Reciprocally Expressing Lymphoid-Myeloid Markers during Dendritic Cell Differentiation |
| Q36261645 | IL-17 producing innate lymphoid cells 3 (ILC3) but not Th17 cells might be the potential danger factor for preeclampsia and other pregnancy associated diseases |
| Q53793238 | IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. |
| Q92786954 | IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease |
| Q57796939 | ILC-poiesis: Ensuring tissue ILC differentiation at the right place and time |
| Q99207719 | ILC1 drive intestinal epithelial and matrix remodelling |
| Q26752285 | ILC1s in Tissue Inflammation and Infection |
| Q92072232 | ILC2s: New Actors in Tumor Immunity |
| Q64066256 | ILC3 function as a double-edged sword in inflammatory bowel diseases |
| Q64080131 | I_MDS: an inflammatory bowel disease molecular activity score to classify patients with differing disease-driving pathways and therapeutic response to anti-TNF treatment |
| Q87427344 | Identification of diverse innate lymphoid cells in human decidua |
| Q90732984 | Imbalance of Circulating Innate Lymphoid Cell Subpopulations in Patients With Septic Shock |
| Q39000249 | Immune modules shared by innate lymphoid cells and T cells |
| Q35667676 | Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4⁺ T cells |
| Q50042967 | Immunological pathogenesis of inflammatory bowel disease. |
| Q92217080 | Increased ILC3s associated with higher levels of IL-1β aggravates inflammatory arthritis in mice lacking phagocytic NADPH oxidase |
| Q48302741 | Infection and depletion of CD4+ group-1 innate lymphoid cells by HIV-1 via type-I interferon pathway. |
| Q58576051 | Inflammation and Gut-Brain Axis During Type 2 Diabetes: Focus on the Crosstalk Between Intestinal Immune Cells and Enteric Nervous System |
| Q40076719 | Inflammatory colonic innate lymphoid cells are increased during untreated hiv-1 infection and associated with markers of gut dysbiosis and mucosal immune activation. |
| Q37693528 | Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs |
| Q35957398 | Innate Immune Defenses Mediated by Two ILC Subsets Are Critical for Protection against Acute Clostridium difficile Infection |
| Q90176757 | Innate Lymphocytes in Psoriasis |
| Q49920496 | Innate Lymphoid Cells (ILCs): Cytokine Hubs Regulating Immunity and Tissue Homeostasis. |
| Q90092769 | Innate Lymphoid Cells at the Maternal-Fetal Interface in Human Pregnancy |
| Q89495092 | Innate Lymphoid Cells in Colorectal Cancers: A Double-Edged Sword |
| Q47554808 | Innate Lymphoid Cells in HIV/SIV Infections |
| Q64058682 | Innate Lymphoid Cells in Helminth Infections-Obligatory or Accessory? |
| Q42683314 | Innate Lymphoid Cells in Intestinal Inflammation |
| Q64255314 | Innate Lymphoid Cells in Mucosal Immunity |
| Q53796096 | Innate Lymphoid Cells in Tumor Immunity. |
| Q90103111 | Innate Lymphoid Cells in the Airways: Their Functions and Regulators |
| Q58707784 | Innate Lymphoid Cells in the Maternal and Fetal Compartments |
| Q64230647 | Innate Lymphoid Cells: A Link between the Nervous System and Microbiota in Intestinal Networks |
| Q89167818 | Innate Lymphoid Cells: Diversity, Plasticity, and Unique Functions in Immunity |
| Q64084898 | Innate Lymphoid Cells: Expression of PD-1 and Other Checkpoints in Normal and Pathological Conditions |
| Q92594507 | Innate Lymphoid Cells: Regulators of Gut Barrier Function and Immune Homeostasis |
| Q88792583 | Innate Recognition of the Microbiota by TLR1 Promotes Epithelial Homeostasis and Prevents Chronic Inflammation |
| Q27010139 | Innate lymphocyte cells in asthma phenotypes |
| Q100517652 | Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer |
| Q104508254 | Innate lymphoid cell composition associates with COVID-19 disease severity |
| Q62733580 | Innate lymphoid cell sensing of tissue vitality |
| Q49980468 | Innate lymphoid cells and allergic disease. |
| Q34895926 | Innate lymphoid cells and the skin |
| Q38872144 | Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis. |
| Q49861059 | Innate lymphoid cells at the human maternal-fetal interface in spontaneous preterm labor. |
| Q94591730 | Innate lymphoid cells control signaling circuits to regulate tissue-specific immunity |
| Q52641247 | Innate lymphoid cells in autoimmunity and chronic inflammatory diseases. |
| Q38985676 | Innate lymphoid cells in autoimmunity: emerging regulators in rheumatic diseases. |
| Q87718734 | Innate lymphoid cells in defense, immunopathology and immunotherapy |
| Q26801315 | Innate lymphoid cells in graft-versus-host disease |
| Q38605374 | Innate lymphoid cells in intestinal immunity and inflammation |
| Q38165175 | Innate lymphoid cells in the defense against infections |
| Q36908615 | Innate lymphoid cells in the initiation, regulation and resolution of inflammation |
| Q27023221 | Innate lymphoid cells in the skin |
| Q40063411 | Innate lymphoid cells in tissue homeostasis and diseases |
| Q37734578 | Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. |
| Q92830433 | Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2 |
| Q27026229 | Innate lymphoid cells, possible interaction with microbiota |
| Q29617431 | Innate lymphoid cells--a proposal for uniform nomenclature |
| Q88990558 | Innate lymphoid cells-key immune integrators of overall body homeostasis |
| Q35638915 | Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology |
| Q92560950 | Innate lymphoid cells: A potential link between microbiota and immune responses against cancer |
| Q38643190 | Innate lymphoid cells: major players in inflammatory diseases |
| Q38916194 | Innate lymphoid cells: models of plasticity for immune homeostasis and rapid responsiveness in protection. |
| Q36288830 | Innate lymphoid cells: new insights into function and development |
| Q52654737 | Innate-like CD8+ T-cells and NK cells: converging functions and phenotypes. |
| Q58419491 | Interactions Between Multipotential Stromal Cells (MSCs) and Immune Cells During Bone Healing |
| Q34397537 | Interactions between the intestinal microbiota and innate lymphoid cells. |
| Q38674886 | Interleukin (IL)-12 and IL-23 and Their Conflicting Roles in Cancer |
| Q57067878 | Interleukin 12/interleukin 23 pathway: Biological basis and therapeutic effect in patients with Crohn's disease |
| Q38183649 | Interleukin 23 in Crohn's disease |
| Q35964497 | Interleukin 6 Increases Production of Cytokines by Colonic Innate Lymphoid Cells in Mice and Patients With Chronic Intestinal Inflammation. |
| Q92538732 | Interleukin-7 Receptor Alpha in Innate Lymphoid Cells: More Than a Marker |
| Q58619639 | Interleukins 12 and 15 induce cytotoxicity and early NK-cell differentiation in type 3 innate lymphoid cells |
| Q64078046 | Intestinal Organoids as a Novel Complementary Model to Dissect Inflammatory Bowel Disease |
| Q38190874 | Intestinal epithelial cells: regulators of barrier function and immune homeostasis |
| Q64100449 | Iron and Ferritin Modulate MHC Class I Expression and NK Cell Recognition |
| Q89348585 | Isolation of Human Innate Lymphoid Cells |
| Q51017443 | Long-term Persistence of Innate Lymphoid Cells in the Gut After Intestinal Transplantation. |
| Q40879937 | Low-Dose Intestinal Trichuris muris Infection Alters the Lung Immune Microenvironment and Can Suppress Allergic Airway Inflammation |
| Q36071413 | Maintaining intestinal health: the genetics and immunology of very early onset inflammatory bowel disease |
| Q26796071 | Maintenance of Immune Homeostasis through ILC/T Cell Interactions |
| Q51557011 | Mass cytometry reveals innate lymphoid cell differentiation pathways in the human fetal intestine. |
| Q33758636 | Mechanisms of innate lymphoid cell and natural killer T cell activation during mucosal inflammation. |
| Q90050659 | Metabolic Control of Innate Lymphoid Cell Migration |
| Q33822367 | Microbiota-derived butyrate suppresses group 3 innate lymphoid cells in terminal ileal Peyer's patches |
| Q36554706 | Migration and Tissue Tropism of Innate Lymphoid Cells |
| Q37721588 | Modeling Human Natural Killer Cell Development in the Era of Innate Lymphoid Cells |
| Q60954864 | Modulating T Cell Responses via Autophagy: The Intrinsic Influence Controlling the Function of Both Antigen-Presenting Cells and T Cells |
| Q42699781 | Modulation of Signal Strength Switches Notch from an Inducer of T Cells to an Inducer of ILC2. |
| Q64074589 | Modulatory Effects of Pregnancy on Inflammatory Bowel Disease |
| Q58105734 | Molecular definition of group 1 innate lymphoid cells in the mouse uterus |
| Q59387548 | Mouse models for the study of fate and function of innate lymphoid cells |
| Q64075903 | NCR group 3 innate lymphoid cells orchestrate IL-23/IL-17 axis to promote hepatocellular carcinoma development |
| Q88013801 | NCR+ ILC3 maintain larger STAT4 reservoir via T-BET to regulate type 1 features upon IL-23 stimulation in mice |
| Q98177647 | NK Cell Development in Times of Innate Lymphoid Cell Diversity |
| Q90226003 | NK Cell Plasticity in Cancer |
| Q26744632 | NK Cells and Other Innate Lymphoid Cells in Hematopoietic Stem Cell Transplantation |
| Q38872138 | NK cells and type 1 innate lymphoid cells: partners in host defense |
| Q40397344 | NK cells are biologic and biochemical targets of 6-mercaptopurine in Crohn's disease patients |
| Q35858827 | NKp46+ Innate Lymphoid Cells Dampen Vaginal CD8 T Cell Responses following Local Immunization with a Cholera Toxin-Based Vaccine. |
| Q37145726 | NKp80 Defines a Critical Step during Human Natural Killer Cell Development |
| Q64979096 | Natural Killer Cells and Type 1 Innate Lymphoid Cells Are New Actors in Non-alcoholic Fatty Liver Disease. |
| Q53579191 | New models of human immunity. |
| Q33835084 | Nod/Ripk2 signaling in dendritic cells activates IL-17A-secreting innate lymphoid cells and drives colitis in T-bet-/-.Rag2-/- (TRUC) mice. |
| Q28079236 | Nod2: A Critical Regulator of Ileal Microbiota and Crohn's Disease |
| Q92469348 | OMIP-055: Characterization of Human Innate Lymphoid Cells from Neonatal and Peripheral Blood |
| Q90845437 | OMIP-062: A 14-Color, 16-Antibody Panel for Immunophenotyping Human Innate Lymphoid, Myeloid and T Cells in Small Volumes of Whole Blood and Pediatric Airway Samples |
| Q48351328 | Old and New Lymphocyte Players in Inflammatory Bowel Disease |
| Q54218424 | Orchestration of intestinal homeostasis and tolerance by group 3 innate lymphoid cells. |
| Q90248096 | Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities |
| Q36106065 | Plasmacytoid dendritic cells promote HIV-1-induced group 3 innate lymphoid cell depletion |
| Q39441262 | Plastic Heterogeneity of Innate Lymphoid Cells in Cancer |
| Q89927095 | Plasticity of innate lymphoid cell subsets |
| Q89965506 | Pleiotropic Role and Bidirectional Immunomodulation of Innate Lymphoid Cells in Cancer |
| Q39623874 | Predominance of Type 1 Innate Lymphoid Cells in the Rectal Mucosa of Patients With Non-Celiac Wheat Sensitivity: Reversal After a Wheat-Free Diet. |
| Q49942221 | Preferential Reduction of Circulating Innate Lymphoid Cells Type 2 in Patients with Common Variable Immunodeficiency with Secondary Complications Is Part of a Broader Immune Dysregulation. |
| Q89685652 | Presence of Inflammatory Group I and III Innate Lymphoid Cells in the Colon of SIV-infected Rhesus Macaques |
| Q92269146 | Presence of innate lymphoid cells in pleural effusions of primary and metastatic tumors: Functional analysis and expression of PD-1 receptor |
| Q92852963 | Programmed Cell Death-1 Receptor (PD-1)-Mediated Regulation of Innate Lymphoid Cells |
| Q53064211 | Reconstitution of multifunctional CD56lowCD16low natural killer cell subset in children with acute leukemia given α/β T cell-depleted HLA-haploidentical haematopoietic stem cell transplantation. |
| Q97521492 | Regulation of Human Innate Lymphoid Cells in the Context of Mucosal Inflammation |
| Q49544001 | Regulation of Innate Lymphoid Cells by Aryl Hydrocarbon Receptor. |
| Q90056696 | Regulation of NK-Cell Function by HLA Class II |
| Q34081391 | Regulation of intestinal health and disease by innate lymphoid cells |
| Q26864694 | Regulation of the adaptive immune system by innate lymphoid cells |
| Q35880427 | Retinoic Acid Differentially Regulates the Migration of Innate Lymphoid Cell Subsets to the Gut. |
| Q36571294 | Retinoic Acid-Related Orphan Receptors (RORs): Regulatory Functions in Immunity, Development, Circadian Rhythm, and Metabolism |
| Q27001687 | Role of group 3 innate lymphoid cells in antibody production |
| Q58746167 | Runx3 Mediates Resistance to Intracellular Bacterial Infection by Promoting IL12 Signaling in Group 1 ILC and NCR+ILC3 |
| Q40101474 | SMAD4 impedes the conversion of NK cells into ILC1-like cells by curtailing non-canonical TGF-β signaling |
| Q50095337 | Shaping Innate Lymphoid Cell Diversity. |
| Q38177789 | Signatures of human NK cell development and terminal differentiation |
| Q93043721 | Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy |
| Q64052778 | Skin immunisation activates an innate lymphoid cell-monocyte axis regulating CD8 effector recruitment to mucosal tissues |
| Q91631661 | Spatial and Temporal Mapping of Human Innate Lymphoid Cells Reveals Elements of Tissue Specificity |
| Q27693895 | Stromal cell regulation of homeostatic and inflammatory lymphoid organogenesis |
| Q92445194 | Suppression of Aiolos and Ikaros expression by lenalidomide reduces human ILC3-ILC1/NK cell transdifferentiation |
| Q35156077 | T cell contamination in flow cytometry gating approaches for analysis of innate lymphoid cells. |
| Q50102251 | T-bet and Eomes govern differentiation and function of mouse and human NK cells and ILC1. |
| Q57793461 | T-bet controls intestinal mucosa immune responses via repression of type 2 innate lymphoid cell function |
| Q39026063 | T-bet in the spot light: roles in distinct T-cell fate determination |
| Q49347756 | T-bet-independent Th1 response induces intestinal immunopathology during Toxoplasma gondii infection. |
| Q38151473 | T-bet: a bridge between innate and adaptive immunity. |
| Q46265247 | TH17 Cell and Epithelial Cell Crosstalk during Inflammatory Bowel Disease and Carcinogenesis. |
| Q38164289 | TLRs to cytokines: mechanistic insights from the imiquimod mouse model of psoriasis |
| Q35581734 | TNF-α Producing Innate Lymphoid Cells (ILCs) Are Increased in Active Celiac Disease and Contribute to Promote Intestinal Atrophy in Mice |
| Q57038953 | Targeting of the nasal mucosa by Japanese encephalitis virus for non-vector-borne transmission |
| Q42375565 | Th1 and Innate Lymphoid Cells Accumulate in Primary Sclerosing Cholangitis-associated Inflammatory Bowel Disease |
| Q38984610 | The Contribution of Small Airway Obstruction to the Pathogenesis of Chronic Obstructive Pulmonary Disease |
| Q37419561 | The Gdac1 locus modifies spontaneous and Salmonella-induced colitis in mice deficient in either Gpx2 or Gpx1 gene |
| Q92239566 | The Influence of Innate Lymphoid Cells and Unconventional T Cells in Chronic Inflammatory Lung Disease |
| Q92538718 | The Interplay Between Innate Lymphoid Cells and the Tumor Microenvironment |
| Q89486269 | The JAK inhibitor ruxolitinib reduces inflammation in an ILC3-independent model of innate immune colitis |
| Q90401345 | The Obese Liver Environment Mediates Conversion of NK Cells to a Less Cytotoxic ILC1-Like Phenotype |
| Q33790954 | The Role of Innate Lymphoid Cells in Immune-Mediated Liver Diseases |
| Q64102236 | The Transcription Factor T-Bet Is Required for Optimal Type I Follicular Helper T Cell Maintenance During Acute Viral Infection |
| Q38319907 | The biology of innate lymphoid cells |
| Q57039150 | The brave new world of innate lymphoid cells |
| Q49925661 | The cytosolic sensor STING is required for intestinal homeostasis and control of inflammation. |
| Q40791214 | The heterogeneity of human CD127(+) innate lymphoid cells revealed by single-cell RNA sequencing |
| Q97530878 | The interplay between innate lymphoid cells and T cells |
| Q35065019 | The microbiome and regulation of mucosal immunity |
| Q26740079 | The origin and role of innate lymphoid cells in the lung |
| Q90589872 | The pathogenic role of innate lymphoid cells in autoimmune-related and inflammatory skin diseases |
| Q89665184 | The role of innate lymphoid cells in response to microbes at mucosal surfaces |
| Q38115440 | The role of the immune system in governing host-microbe interactions in the intestine |
| Q89282567 | The roles for innate lymphoid cells in the human immune system |
| Q34105699 | The roles of innate lymphoid cells in the development of asthma |
| Q42262891 | The transcription Factor AHR prevents the differentiation of a stage 3 innate lymphoid cell subset to natural killer cells. |
| Q33634144 | The transcription factor GATA3 is critical for the development of all IL-7Rα-expressing innate lymphoid cells |
| Q38478216 | The unusual suspects--innate lymphoid cells as novel therapeutic targets in IBD. |
| Q59792624 | Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells |
| Q50133227 | Tissue-Resident Cytolytic Innate Lymphocytes in Cancer. |
| Q64090873 | Tissue-resident Eomes NK cells are the major innate lymphoid cell population in human infant intestine |
| Q38089253 | Tissue-specific effector functions of innate lymphoid cells. |
| Q36358937 | Transcription factor networks directing the development, function, and evolution of innate lymphoid effectors |
| Q100395393 | Transcription tipping points for T follicular helper cell and T-helper 1 cell fate commitment |
| Q89621143 | Transcriptional and Functional Programming of Decidual Innate Lymphoid Cells |
| Q38525099 | Transcriptional regulation of innate lymphoid cell fate. |
| Q52879143 | Transcriptionally defining ILC heterogeneity in humans. |
| Q33799561 | Transcriptome analysis reveals similarities between human blood CD3- CD56bright cells and mouse CD127+ innate lymphoid cells. |
| Q94521908 | Transdifferentiation of tumor infiltrating innate lymphoid cells during progression of colorectal cancer |
| Q64065227 | Transient Expression of GATA3 in Hematopoietic Stem Cells Facilitates Helper Innate Lymphoid Cell Differentiation |
| Q28829881 | Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells |
| Q90000019 | True Detective: Unraveling Group 1 Innate Lymphocyte Heterogeneity |
| Q91168567 | Two distinct colonic CD14+ subsets characterized by single-cell RNA profiling in Crohn's disease |
| Q28066387 | Type 1 Innate Lymphoid Cell Biology: Lessons Learnt from Natural Killer Cells |
| Q64251722 | Type 2 Innate Lymphoid Cells in Liver and Gut: From Current Knowledge to Future Perspectives |
| Q57181216 | Type 2 innate lymphoid cells in the induction and resolution of tissue inflammation |
| Q90388993 | Type 3 Immunity during Clostridioides difficile Infection: Too Much of a Good Thing? |
| Q36299851 | Type 3 innate lymphoid cell depletion is mediated by TLRs in lymphoid tissues of simian immunodeficiency virus-infected macaques |
| Q39402904 | Type two innate lymphoid cells: the Janus cells in health and disease. |
| Q97546129 | Umbilical cord blood-derived ILC1-like cells constitute a novel precursor for mature KIR+NKG2A- NK cells |
| Q36694912 | Unique Eomes(+) NK Cell Subsets Are Present in Uterus and Decidua During Early Pregnancy. |
| Q38865721 | Vitamins A and D have antagonistic effects on expression of effector cytokines and gut-homing integrin in human innate lymphoid cells. |
| Q38809547 | What rheumatologists need to know about innate lymphocytes |
| Q28079656 | When Insult Is Added to Injury: Cross Talk between ILCs and Intestinal Epithelium in IBD |
| Q56873607 | Will the real ILC1 please stand up? |
| Q91530400 | c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies |
| Q90388552 | c-Maf regulates the plasticity of group 3 innate lymphoid cells by restraining the type 1 program |
| Q89625928 | c-Maf restrains T-bet-driven programming of CCR6-negative group 3 innate lymphoid cells |
Search more.